Table 3.
Correlations among the molecular signatures
Correlation coefficient | |||||
---|---|---|---|---|---|
Concordance (P value) | |||||
p53 wt | 70-Gene low | Luminal | Wound-quiescent | ROR-S low | |
HR+, HER2− | 0.44 | 0.26 | 0.62 | 0.34 | 0.40 |
0.72 | 0.63 | 0.81 | 0.68 | 0.71 | |
(<0.001) | (0.002) | (<0.001) | (<0.001) | (<0.001) | |
p53 wt | ⇓ | 0.32 | 0.65 | 0.55 | 0.56 |
⇒ | 0.59 | 0.83 | 0.73 | 0.74 | |
(<0.001) | (<0.001) | (<0.001) | (<0.001) | ||
70-Gene low | ⇓ | 0.33 | 0.41 | 0.54 | |
⇒ | 0.61 | 0.82 | 0.83 | ||
(<0.001) | (<0.001) | (<0.001) | |||
Luminal | ⇓ | 0.40 | 0.55 | ||
⇒ | 0.68 | 0.75 | |||
(<0.001) | (<0.001) | ||||
Wound-quiescent | ⇓ | 0.63 | |||
⇒ | 0.86 | ||||
(<0.001) |
HR hormone receptor, wt wild type, ROR-S risk of relapse score. Signatures are shown as dichotomies: HR+/HER2− vs. not, luminal (A and B) vs. the other intrinsic subtypes (HER2 enriched, basal, and normal-like), p53 wild type vs. mutation, 70-gene prognosis low vs. high (only 13 (9%) patients are in the low risk prognosis group), and wound-quiescent vs. wound-activated. Concordance refers to the lower risk subsets